The MAPK/ERK signaling pathway is another critical target for inhibitors. This pathway is involved in managing cell survival, development, and differentiation. Inhibitors targeting MAPK/ERK are utilized in cancer therapies to stop unrestrained cell proliferation and tumor development. In a similar way, JAK/STAT signaling inhibitors regulate immune